Recently, several autoimmune neurological diseases have been defined by the presence of autoantibodies against different antigens of the nervous system. These autoantibodies have been demonstrated to be specific and useful biomarkers, and most of them are also pathogenic. These aspects have increased the value of autoantibodies in neurological practice, as they enable to establish more accurate diagnosis and to better understand the underlying mechanisms of the autoimmune neurological diseases when they are compared to those lacking them. Nevertheless, the exact mechanisms leading to the autoimmune response are still obscure. Genetic predisposition is likely to play a role in autoimmunity, HLA being the most reported genetic factor. Herein, we review the current knowledge about associations between HLA and autoimmune neurological diseases with autoantibodies. We report the main alleles and haplotypes, and discuss the clinical and pathogenic implications of these findings.
Keywords: Autoantibodies; Autoimmune encephalitis; HLA; Limbic encephalitis; Myasthenia gravis; Neuromyelitis optica; Paraneoplastic neurological syndrome.
Conflict of interest statement
The authors declare that they have no competing interests.
Biochemical markers of autoimmune diseases of the nervous system.Curr Pharm Des. 2012;18(29):4556-63. doi: 10.2174/138161212802502143. Curr Pharm Des. 2012. PMID: 22612740 Review.
Autoantibody-mediated disorders of the central nervous system.Autoimmunity. 2008 Feb;41(1):55-65. doi: 10.1080/08916930701619490. Autoimmunity. 2008. PMID: 18176865 Review.
Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.J Neural Transm (Vienna). 2014 Aug;121(8):1029-75. doi: 10.1007/s00702-014-1193-3. Epub 2014 Aug 1. J Neural Transm (Vienna). 2014. PMID: 25081016 Review.
Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma.JAMA Neurol. 2016 Jul 1;73(7):853-9. doi: 10.1001/jamaneurol.2016.0603. JAMA Neurol. 2016. PMID: 27135398
A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica.Autoimmunity. 2014 May;47(3):154-61. doi: 10.3109/08916934.2014.883501. Epub 2014 Feb 10. Autoimmunity. 2014. PMID: 24512514 Review.